WO2001068889A3 - Method for gene transfection and vaccination through skin using electropermeabilization - Google Patents
Method for gene transfection and vaccination through skin using electropermeabilization Download PDFInfo
- Publication number
- WO2001068889A3 WO2001068889A3 PCT/US2001/008502 US0108502W WO0168889A3 WO 2001068889 A3 WO2001068889 A3 WO 2001068889A3 US 0108502 W US0108502 W US 0108502W WO 0168889 A3 WO0168889 A3 WO 0168889A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- gene
- polynucleotide
- approach
- individual
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000004520 electroporation Methods 0.000 title 1
- 238000012637 gene transfection Methods 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 210000004400 mucous membrane Anatomy 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000005684 electric field Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
- A61N1/0416—Anode and cathode
- A61N1/0424—Shape of the electrode
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001250859A AU2001250859A1 (en) | 2000-03-16 | 2001-03-16 | Method for gene transfection and vaccination through skin using electropermeabilization |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18984700A | 2000-03-16 | 2000-03-16 | |
US60/189,847 | 2000-03-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001068889A2 WO2001068889A2 (en) | 2001-09-20 |
WO2001068889A3 true WO2001068889A3 (en) | 2002-04-25 |
Family
ID=37488067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/008502 WO2001068889A2 (en) | 2000-03-16 | 2001-03-16 | Method for gene transfection and vaccination through skin using electropermeabilization |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001250859A1 (en) |
WO (1) | WO2001068889A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006119983A2 (en) | 2005-05-12 | 2006-11-16 | Novartis Ag | Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
US20080033398A1 (en) * | 2005-12-29 | 2008-02-07 | Transcutaneous Technologies Inc. | Device and method for enhancing immune response by electrical stimulation |
EP3018139A3 (en) | 2007-08-03 | 2016-08-10 | Boehringer Ingelheim Vetmedica GmbH | Genes and proteins of brachyspira hyodysenteriae and uses thereof |
GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
EP2363407A1 (en) | 2008-02-28 | 2011-09-07 | Murdoch University | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
WO2009117773A1 (en) | 2008-03-27 | 2009-10-01 | Murdoch University | Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
ITCO20080016A1 (en) * | 2008-04-22 | 2009-10-23 | Giuseppe Caccia | HANDPIECE FOR THE ELECTROPORATION OF PHARMACOLOGICAL AND / OR NATURAL AND / OR AESTHETIC PRODUCTS ON LAYERS CUTANEOUS WITH THICKNESS CONTENT |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019034A (en) * | 1988-01-21 | 1991-05-28 | Massachusetts Institute Of Technology | Control of transport of molecules across tissue using electroporation |
WO1991018103A1 (en) * | 1990-05-16 | 1991-11-28 | Scientific Equipment Design & Development S.C. | Method and device for making living cells permeable |
WO1996039531A1 (en) * | 1995-06-06 | 1996-12-12 | Massachusetts Institute Of Technology | Delivery of nucleotides into organisms by electroporation |
WO1997007826A1 (en) * | 1995-08-29 | 1997-03-06 | Cbr Laboratories, Inc. | In vivo electroporation of cells |
WO1999064615A1 (en) * | 1998-06-08 | 1999-12-16 | Valentis, Inc. | Formulations for electroporation |
-
2001
- 2001-03-16 AU AU2001250859A patent/AU2001250859A1/en not_active Abandoned
- 2001-03-16 WO PCT/US2001/008502 patent/WO2001068889A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019034A (en) * | 1988-01-21 | 1991-05-28 | Massachusetts Institute Of Technology | Control of transport of molecules across tissue using electroporation |
US5019034B1 (en) * | 1988-01-21 | 1995-08-15 | Massachusetts Inst Technology | Control of transport of molecules across tissue using electroporation |
WO1991018103A1 (en) * | 1990-05-16 | 1991-11-28 | Scientific Equipment Design & Development S.C. | Method and device for making living cells permeable |
WO1996039531A1 (en) * | 1995-06-06 | 1996-12-12 | Massachusetts Institute Of Technology | Delivery of nucleotides into organisms by electroporation |
WO1997007826A1 (en) * | 1995-08-29 | 1997-03-06 | Cbr Laboratories, Inc. | In vivo electroporation of cells |
WO1999064615A1 (en) * | 1998-06-08 | 1999-12-16 | Valentis, Inc. | Formulations for electroporation |
Non-Patent Citations (4)
Title |
---|
BANGA A K ET AL: "Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 16, no. 10, 1 October 1998 (1998-10-01), pages 408 - 412, XP004145647, ISSN: 0167-7799 * |
BARON S ET AL: "Electroporation of antibodies, DNA, and other macromolecules into cells: a highly efficient method", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 242, no. 1-2, 28 August 2000 (2000-08-28), pages 115 - 126, XP004210715, ISSN: 0022-1759 * |
JOSEPH J. DRABICK ET AL: "Cutaneous Transfection and Immune Responses to Intradermal Nucleic Acid accination Are Significantly Enhanced by in Vivo Electropermeabilization", MOLECULAR THERAPY, vol. 3, no. 2, February 2001 (2001-02-01), pages 249 - 255, XP002190195 * |
SELBY M ET AL: "Enhancement of DNA vaccine potency by electroporation in vivo", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 83, no. 1-2, 29 September 2000 (2000-09-29), pages 147 - 152, XP004212162, ISSN: 0168-1656 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001068889A2 (en) | 2001-09-20 |
AU2001250859A1 (en) | 2001-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Langevin et al. | Mechanical signaling through connective tissue: a mechanism for the therapeutic effect of acupuncture | |
Cabelguen et al. | Bimodal locomotion elicited by electrical stimulation of the midbrain in the salamander Notophthalmus viridescens | |
CN104136071B (en) | For stimulating natural on-off cycles of hair growth and/or avoiding the apparatus and method of alopecia | |
CN1678369A (en) | Electro-perforation device and injection apparatus | |
NO913700D0 (en) | EXPRESSION OF EXOGENIC POLYNUCLEOTIDE SEQUENCES IN AN ANIMAL ANIMAL. | |
ATE185083T1 (en) | DEVICE FOR ADMINISTRATION OF MEDICATIONS AND GENES BY ELECTROPORATION | |
AU5787394A (en) | Particle-mediated transformation of animal somatic cells | |
IL134842A0 (en) | Method of delivering genes to antigen presenting cells of the skin | |
NZ514228A (en) | Method of Expressing Antigens on the Surface of Antigen Presenting Cells by Photochemical Internalisation | |
NO960309L (en) | Agonists and antagonists of human interleukin-10 | |
WO2001068889A3 (en) | Method for gene transfection and vaccination through skin using electropermeabilization | |
PL1699480T3 (en) | Allogeneic tumor therapeutic agent | |
WO2001068828A3 (en) | Compositions and methods for regulated protein expression in gut | |
AU2003246537A1 (en) | Device for needle-free injection of a medium into the tissue of a human or an animal, device for needle free production of an injection channel and method for the needle free injection of a medium in the tissue | |
KR20180034596A (en) | Hair Growth Stimulation | |
CN106614361B (en) | A kind of sheep reduced before butchering stress processing method | |
JPWO2006120767A1 (en) | Spa device for hand treatment and spa method for hand treatment | |
KR101713061B1 (en) | Strengthener Of Muscle Around Mouth | |
WO2001009611A3 (en) | An vivo identification of specific binding molecules for cancer detection | |
AU3259901A (en) | Transgenic animal model for obesity expressing foxc2 | |
EP1151756A4 (en) | Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus | |
WO2002068629A3 (en) | Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same | |
AU4037299A (en) | Genetically-modified fibroblasts and the use thereof | |
WO1999045116A3 (en) | Human homolog of a nuclear migration gene and its use | |
Minenko et al. | The method of determining the number of excited efferent cardiac fibers in the vagus nerve of a cat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |